权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Cerebellar pathology in the absence of plasticity gating

缺乏可塑性门控的小脑病理学

基本信息

批准号：
10289334
负责人：
Jason M Christie
金额：
$ 48.25万
依托单位：
UNIVERSITY OF TEXAS HLTH SCIENCE CENTER
依托单位国家：
美国
项目类别：
财政年份：
2021
资助国家：
美国
起止时间：
2021-07-01 至 2026-04-30
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10289334
关键词：
Affect Agreement Animals Attention deficit hyperactivity disorder Automobile Driving Behavior Behavioral Brain Brain Diseases Calcium Calcium Signaling Cells Cerebellar Diseases Cerebellum Chronic Conflict (Psychology)Custom Data Dendrites Disease Disinhibition Duchenne muscular dystrophy Dystrophin Engineering Etiology Exhibits Fiber Fire - disasters Functional disorder Goals Health Human Impairment Inferior Inhibitory Synapse Interneurons Learning Link Long-Term Depression Mediating Molecular Genetics Mus Muscular Atrophy Neurobiology Neurologic Neurologic Symptoms Olives - dietary Outcome Pathologic Pathology Patients Performance Pharmaceutical Preparations Pharmacology Process Purkinje Cells Regulation Role Structure of molecular layer of cerebellar cortex Symptoms Synapses Testing Therapeutic Transgenic Mice Wild Type Mouse Work autism spectrum disorder base behavior test behavioral phenotyping cell type cognitive disability comorbidity dystrophinopathy expectation genetic technology improved in vivo insight interdisciplinary approach mouse model nervous system disorder neural circuit novel prevent receptor relating to nervous system response synaptic function therapeutic target therapy development treatment strategy

项目摘要

PROJECT SUMMARY/ABSTRACT Dystrophin deficiency, which occurs in Duchenne muscular dystrophy (DMD), results in muscle wasting. As dystrophin is expressed in the brain, its deficiency also contributes to neurological symptoms in DMD patients. Cerebellar Purkinje cells in mouse models of DMD have weaker inhibitory synaptic connections and compromised climbing-fiber-evoked plasticity. This implicates cerebellar dysfunction as a contributing factor to the neurological pathophysiology of DMD. Yet, how cerebellar dysfunction ultimately explains DMD neurological symptoms remains incompletely understood. Increasing evidence points to the importance of plasticity gating to maintain a reserve capacity for learning. In Purkinje cells, a candidate gating mechanism of plasticity induction is inhibition from molecular layer interneurons, which suppresses the evoked calcium response to climbing fiber excitation that triggers induction of long-term depression (LTD). Therefore, the objective of this study is to test for a potential synergistic role of inhibitory synapse weakening and compromised LTD in dystrophinopathy and determine if increasing GABAA receptor responsiveness specifically in Purkinje cells restores a high threshold for plasticity induction and thus provide a potential therapeutic strategy to ameliorate cerebellar dysfunction. We will employ a multidisciplinary approach encompassing the use of ex vivo and in vivo functional recordings in Purkinje-cell-autonomous dystrophin-deficient mice, cell-type specific neuropharmacological perturbations, and behavioral analyses. Through two aims, we will test correlative and causative links between aberrant neural circuit responsiveness, spurious plasticity, and cerebellar learning abnormalities. Completion of these aims will contribute novel insights into plasticity regulation, the etiology of neurological impairment in DMD, and potential avenues for treating cerebellum-related symptoms of this disorder.

项目摘要/摘要营养不良蛋白缺乏症发生在Duchenne肌营养不良症(DMD)，导致肌肉萎缩。AS Dstrophin在大脑中表达，它的缺乏也导致DMD患者的神经症状。 DMD模型小鼠小脑浦肯野细胞抑制性突触连接较弱，受损的攀爬纤维引起的可塑性。这意味着小脑功能障碍是一个促成因素。 DMD的神经病理生理学。然而，小脑功能障碍最终如何解释DMD神经学症状仍不完全清楚。越来越多的证据表明，塑性浇注对保持学习的后备能力。在浦肯野细胞中，可塑性诱导的候选门控机制是来自分子层中间神经元的抑制，它抑制了对攀升纤维的诱发钙反应引发长期抑郁(LTD)的兴奋。因此，本研究的目的是验证抑制性突触减弱和受损的LTD在营养不良和营养不良中的潜在协同作用确定在浦肯野细胞中特异性增加GABAA受体反应性是否能恢复高阈值用于可塑性诱导，从而提供一种潜在的治疗策略来改善小脑功能障碍。我们将采用多学科方法，包括使用体外和体内功能录音在浦肯野细胞自主性营养不良蛋白缺陷小鼠，细胞类型特异性神经药理学干扰，以及行为分析。通过两个目标，我们将检验异常神经之间的相关和因果联系回路反应、假性可塑性和小脑学习异常。完成这些目标将对可塑性调节、DMD神经损害的病因和潜力提供新的见解治疗这种疾病的小脑相关症状的途径。